Literature DB >> 4154124

Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms.

D A Warrell, N M Davidson, L D Omerod, H M Pope, B J Watkins, B M Greenwood, H A Ried.   

Abstract

Echis carinatus is the most important cause of morbidity and mortality from snake bite in Nigeria and in many other parts of the world. Forty-six patients with systemic poisoning by this snake were given echis antivenom made either by the South African Institute for Medical Research (S.A.I.M.R.) or by Behringwerke (North and West African polyvalent antivenom). A simple test of blood coagulability was used to assess whether an adequate neutralizing dose of antivenom had been given. An average of 15.2 ml S.A.I.M.R. antivenom restored normal coagulability permanently in all 23 patients in one group, but in the other group receiving an average dose of 37.9 ml Behringwerke antivenom normal clotting resulted in only 18 out of 23 patients. Local tissue swelling was similar in both groups, but local necrosis occurred in three patients treated with Behringwerke antivenom and in none given S.A.I.M.R. antivenom.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4154124      PMCID: PMC1612524          DOI: 10.1136/bmj.4.5942.437

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  SPECIFIC ANTIVENENE AND PREDNISONE IN VIPER-BITE POISONING: CONTROLLED TRIAL.

Authors:  H A REID; P C THEAN; W J MARTIN
Journal:  Br Med J       Date:  1963-11-30

2.  Clinical effects of bites by Malayan viper (Ancistrodon rhodostoma).

Authors:  H A REID; P C THEAN; K E CHAN; A R BAHAROM
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

3.  [Poisoning by Echis carinatus Schn. in the region of Sokodé (North Togo)].

Authors:  G SALOU
Journal:  Med Trop (Mars)       Date:  1951 Jul-Aug
  3 in total
  11 in total

1.  Saw-scaled viper bites in Sri Lanka: is it a different subspecies? Clinical evidence from an authenticated case series.

Authors:  Ariaranee Gnanathasan; Chaturaka Rodrigo; Thambipillai Peranantharajah; Anthonia Coonghe
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.

Authors:  Stuart Ainsworth; Stefanie K Menzies; Nicholas R Casewell; Robert A Harrison
Journal:  PLoS Negl Trop Dis       Date:  2020-08-20

3.  Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.

Authors:  Isa S Abubakar; Saidu B Abubakar; Abdulrazaq G Habib; Abdulsalam Nasidi; Nandul Durfa; Peter O Yusuf; Solomon Larnyang; John Garnvwa; Elijah Sokomba; Lateef Salako; R David G Theakston; Ed Juszczak; Nicola Alder; David A Warrell
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

4.  Development of simple standard assay procedures for the characterization of snake venom.

Authors:  R D Theakston; H A Reid
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

5.  Integrating Top-Down and Bottom-Up Mass Spectrometric Strategies for Proteomic Profiling of Iranian Saw-Scaled Viper, Echis carinatus sochureki, Venom.

Authors:  Parviz Ghezellou; Wendell Albuquerque; Vannuruswamy Garikapati; Nicholas R Casewell; Seyed Mahdi Kazemi; Alireza Ghassempour; Bernhard Spengler
Journal:  J Proteome Res       Date:  2020-11-22       Impact factor: 5.370

6.  Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?

Authors:  Emilie Alirol; Pauline Lechevalier; Federica Zamatto; François Chappuis; Gabriel Alcoba; Julien Potet
Journal:  PLoS Negl Trop Dis       Date:  2015-09-10

7.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

8.  Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.

Authors:  Julien Potet; James Smith; Lachlan McIver
Journal:  PLoS Negl Trop Dis       Date:  2019-06-24

Review 9.  Bedside Coagulation Tests in Diagnosing Venom-Induced Consumption Coagulopathy in Snakebite.

Authors:  Supun Wedasingha; Geoffrey Isbister; Anjana Silva
Journal:  Toxins (Basel)       Date:  2020-09-10       Impact factor: 4.546

10.  Indian Polyvalent Antivenom Accelerates Recovery From Venom-Induced Consumption Coagulopathy (VICC) in Sri Lankan Russell's Viper (Daboia russelii) Envenoming.

Authors:  Anjana Silva; Fiona E Scorgie; Lisa F Lincz; Kalana Maduwage; Sisira Siribaddana; Geoffrey K Isbister
Journal:  Front Med (Lausanne)       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.